Literature DB >> 16598437

Antiangiogenic effect of 2-benzoyl-phenoxy acetamide in EAT cell is mediated by HIF-1alpha and down regulation of VEGF of in-vivo.

B T Prabhakar1, Shaukath Ara Khanum, S Shashikanth, Bharathi P Salimath.   

Abstract

Benzophenones and its analogues are known for wide range of biological properties. Synthetic benzophenone analogue 2-benzoyl -phenoxy acetamide (BP-1) is proven to be potent antitumor and proapoptotic activity against EAT cells in-vivo. In the present report, we studied the antiangiogenic effect of BP-1 in EAT cells induced angiogenesis. Treatment with BP-1 in-vivo was demonstrated by the down regulation of the secretion of VEGF from EAT cells and inhibition of blood vessels formation indicating the potential angioinhibitory effect of BP-1 in EAT cells. HIF-1alpha protein, a transcription factor known to be key a regulator in hypoxia-induced angiogenesis was also down regulated by BP-1. Our findings indicated that, HIF-1alpha nuclear sequestration is repressed by BP-1 through inhibition of nuclear translocation. We postulate that diminished HIF-1alpha nuclear presence and activity in BP-1 treated EAT cells could be responsible for decreased VEGF expression and antiangiogenic effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598437     DOI: 10.1007/s10637-006-6587-0

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  35 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation.

Authors:  G Helmlinger; F Yuan; M Dellian; R K Jain
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Oxygen dependent regulation of DNA synthesis and growth of Ehrlich ascites tumor cells in vitro and in vivo.

Authors:  H Probst; H Schiffer; V Gekeler; H Kienzle-Pfeilsticker; U Stropp; K E Stötzer; I Frenzel-Stötzer
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

4.  VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence.

Authors:  B Stoelcker; B Echtenacher; H A Weich; H Sztajer; D J Hicklin; D N Männel
Journal:  J Interferon Cytokine Res       Date:  2000-05       Impact factor: 2.607

5.  Suppression of ascites formation and re-accumulation associated with human ovarian cancer by an anti-VPF monoclonal antibody in vivo.

Authors:  A Yukita; M Asano; T Okamoto; S Mizutani; H Suzuki
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

6.  Polyprenylated benzophenones from Garcinia assigu and their potential cancer chemopreventive activities.

Authors:  Chihiro Ito; Masataka Itoigawa; Yoshiaki Miyamoto; Saori Onoda; K Sundar Rao; Teruo Mukainaka; Harukuni Tokuda; Hoyoku Nishino; Hiroshi Furukawa
Journal:  J Nat Prod       Date:  2003-02       Impact factor: 4.050

7.  Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites.

Authors:  Masahiro Inoue; Mutsuko Mukai; Yukou Hamanaka; Masaharu Tatsuta; Masahiro Hiraoka; Shinae Kizaka-Kondoh
Journal:  Int J Oncol       Date:  2004-09       Impact factor: 5.650

Review 8.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

9.  Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors.

Authors:  J C Luo; S Yamaguchi; A Shinkai; K Shitara; M Shibuya
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

10.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more
  1 in total

1.  Marsdenia tenacissima extract suppresses tumor growth and angiogenesis in A20 mouse lymphoma.

Authors:  Xingbin Dai; Yanhua Ji; Pengjun Jiang; Xuemei Sun
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.